Company Filing History:
Years Active: 2014-2024
Title: Johann Bauer: Innovator in Genetic Research
Introduction
Johann Bauer is a notable inventor based in Salzburg, Austria. He has made significant contributions to the field of genetic research, particularly in the development of methods and systems that address critical issues in gene translation and cancer treatment. With a total of 3 patents, his work has the potential to impact various medical applications.
Latest Patents
One of Johann Bauer's latest patents is titled "Method for identifying interventions that control the translational activity of ribosomal proteins in differential mRNA expression." This invention relates to systems and methods for screening compounds and/or mutant ribosomal proteins in eukaryotic cells. The goal is to increase or decrease the translation of a target gene, thereby ameliorating or reverting defective translation associated with genetic diseases such as Epidermolysis bullosa. The patent also includes diagnostic measures for clinical evaluation and kits comprising the identified compounds and proteins.
Another significant patent is the "RNA trans-splicing molecule (RTM) for use in the treatment of cancer." This invention introduces a novel pre-mRNA trans-splicing molecule that targets tumor-associated genes. It encodes for a suicide gene, specifically thymidine kinase from herpes simplex virus, which selectively kills cells expressing the associated gene. This innovation is particularly useful in treating squamous cell carcinoma related to epidermolysis bullosa.
Career Highlights
Throughout his career, Johann Bauer has worked with various companies, including Breitenbach-Koller, Hannelore. His experience in these organizations has contributed to his expertise in genetic research and innovation.
Collaborations
Johann has collaborated with notable individuals in his field, including Lloyd G Mitchell and Christina Gruber. These partnerships have likely enhanced his research and development efforts.
Conclusion
Johann Bauer's contributions to genetic research through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant breakthroughs in the treatment of genetic diseases and cancer.